Previous 10 | Next 10 |
2023-10-03 17:29:36 ET Gainers: Edgewise Therapeutics ( NASDAQ: EWTX ) +7% . Cantaloupe ( CTLP ) +6% . Computer Programs and Systems ( CPSI ) +6% . REGENXBIO ( RGNX ) +5% . Tandem Diabetes Care ( TNDM ) +5% . Lose...
2023-09-20 11:55:57 ET More on Health Care Sector: Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Health Care Select Sector SPDR ETF declares quarterly distribution of $0.5395 BofA clients were net buyers of U.S. equities for a fifth consecutiv...
2023-09-15 16:49:26 ET Gainers: Omeros Corporation ( NASDAQ: OMER ) +5% . The Lovesac Company ( LOVE ) +4% . Patriot Transportation ( PATI ) +3% . Cipher Mining ( CIFR ) +2% . Humacyte ( HUMA ) +2% . Losers: San...
2023-08-24 08:00:00 ET Summary Omeros focuses on immunologic disorders; faces FDA approval challenges for lead drug narsoplimab. Q2 2023 reports net loss of $37.3M; significant debt and rising expenses threaten financial stability. Investment recommendation: "Sell" due to fina...
2023-08-23 07:30:49 ET Summary Omeros' "Buy" stance is based on upcoming developments in the second half of 2023-2024 around narsoplimab. OMER is expected to present a detailed analysis strategy for the narsoplimab BLA's reapplication for HSCT-TMA, leading to a potential PDUFA by ...
2023-08-09 13:28:16 ET Omeros Corporation (OMER) Q2 2023 Earnings Conference Call August 09, 2023, 08:30 ET Company Participants Jennifer Williams - IR Gregory Demopulos - Co-Founder, Chairman, CEO & President Michael Jacobsen - CAO, VP, Finance & Treasur...
2023-08-09 08:04:18 ET Omeros press release ( NASDAQ: OMER ): Q2 GAAP EPS of -$0.70 misses by $0.13 . Cash burn for the quarter ended June 30, 2023 was $30.1 million, an amount artificially inflated by $3.4 million corresponding to Rayner’s late payment of royal...
– Conference Call Today at 8:30 a.m. ET – Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immuno...
2023-08-08 12:43:26 ET Omeros ( NASDAQ: OMER ) is scheduled to announce Q2 earnings results on Wednesday, August 9th, before market open. The consensus EPS Estimate is -$0.53 and the consensus Revenue Estimate is $0M. Over the last 1 year, OMER has beaten EPS estimat...
2023-08-08 10:46:10 ET Major earnings expected before the bell on Wednesday include: Brookfield Asset Management ( BAM ) 3D Systems ( DDD ) PENN Entertainment ( PENN ) Roblox ( RBLX ) Sony Group ( SONY ) For further details see: Notable ea...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 09:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
$118.1 million, or 55%, of outstanding convertible notes due in 2026 repurchased at approximately 75% of notional value, resulting in $51 million in total debt extinguishment Repurchase funded from new $67 million secured four-year term loan maturing in June 2028 together with $21 million...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 419.5% to $0.24 on volume of 2,920,436,648 shares Greenwave Technology Solutions Inc. (GWAV) rose 147.7% to $0.1481 on volume of 1,864,631,229 shares Faraday Future Intelligent Electric Inc. (FF...